Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30
- PMID: 10561373
- DOI: 10.1200/JCO.1999.17.9.2932
Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30
Abstract
Purpose: To compare two quality-of-life (QOL) questionnaires for cancer patients, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (Fact-G), on the basis of empirical data.
Patients and methods: Two hundred forty-four patients with a diagnosis of breast cancer or Hodgkin's disease completed both the EORTC QLQ-C30 and the FACT-G (German language version) during the same session. Questionnaire data were analyzed on a subscale basis using correlation analysis, canonical correlation, and multiple linear regression.
Results: Correlations between corresponding subscales of the FACT-G and the EORTC QLQ-C30 ranged from r =.14 for the social domain (very poor agreement) to r =.66 for the physical domain (good agreement), with r values for the other domains lying between these extremes. Canonical correlation analysis for the two sets of subscales revealed that overall agreement between the two instruments was only moderate (first canonical correlation coefficient r =.85, but overall redundancy less than 40%). Of the five FACT-G subscales, only one, physical well-being, was well represented by the EORTC QLQ-C30 subscales (multiple linear regression, R(2) =.67). Only three of eight EORTC QLQ-C30 subscales (physical functioning, global QOL, general symptoms) were represented fairly well by FACT-G subscales (R(2) =.43 to.60). The lowest R(2) values (<.15; ie, virtually no representation by the other instrument) were found for the FACT-G social well-being and relation with doctors and EORTC QLQ-C30 cognitive functioning subscales.
Conclusion: For the sample investigated, the EORTC QLQ-C30 and the FACT-G were found to measure markedly different aspects of QOL, despite considerable overlap. Replicability provided, this implies that neither of the two QOL instruments can be replaced by the other and that a direct comparison of results obtained with the two instruments is not possible.
Similar articles
-
EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison.Eur J Haematol. 2000 Aug;65(2):97-103. doi: 10.1034/j.1600-0609.2000.90143.x. Eur J Haematol. 2000. PMID: 10966168 Clinical Trial.
-
The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.Eur J Cancer Care (Engl). 2004 May;13(2):135-44. doi: 10.1111/j.1365-2354.2003.00435.x. Eur J Cancer Care (Engl). 2004. PMID: 15115469
-
EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.Eur J Oncol Nurs. 2013 Dec;17(6):849-55. doi: 10.1016/j.ejon.2013.05.006. Epub 2013 Jul 11. Eur J Oncol Nurs. 2013. PMID: 23850411
-
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.Ann Oncol. 1998;9 Suppl 5:S147-54. doi: 10.1093/annonc/9.suppl_5.s147. Ann Oncol. 1998. PMID: 9926255 Review.
-
Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.Support Care Cancer. 2016 Aug;24(8):3661-8. doi: 10.1007/s00520-016-3270-7. Epub 2016 May 18. Support Care Cancer. 2016. PMID: 27193118 Review.
Cited by
-
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.Health Qual Life Outcomes. 2016 Mar 25;14:52. doi: 10.1186/s12955-016-0449-z. Health Qual Life Outcomes. 2016. PMID: 27016084 Free PMC article. Clinical Trial.
-
Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054).J Cancer Res Clin Oncol. 2011 Jan;137(1):99-113. doi: 10.1007/s00432-010-0864-1. Epub 2010 Apr 14. J Cancer Res Clin Oncol. 2011. PMID: 20390429 Free PMC article. Clinical Trial.
-
Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.Qual Life Res. 2005 Sep;14(7):1693-703. doi: 10.1007/s11136-005-2816-9. Qual Life Res. 2005. PMID: 16119181
-
Development of a short form of the Singapore Caregiver Quality of Life Scale - Dementia: SCQOLS-D-15.J Patient Rep Outcomes. 2021 Jul 10;5(1):56. doi: 10.1186/s41687-021-00330-0. J Patient Rep Outcomes. 2021. PMID: 34245389 Free PMC article.
-
Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy.Health Qual Life Outcomes. 2018 Sep 14;16(1):183. doi: 10.1186/s12955-018-1012-x. Health Qual Life Outcomes. 2018. PMID: 30217200 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical